Loading...
XSHE
002788
Market cap578mUSD
Jul 10, Last price  
10.28CNY
1D
1.78%
1Q
-32.68%
Jan 2017
-52.30%
IPO
-4.73%
Name

Luyan Pharma Co Ltd

Chart & Performance

D1W1MN
XSHE:002788 chart
P/E
14.22
P/S
0.19
EPS
0.72
Div Yield, %
3.47%
Shrs. gr., 5y
0.07%
Rev. gr., 5y
3.90%
Revenues
21.25b
+3.79%
2,948,581,4964,687,352,4365,519,752,1546,299,801,6926,625,719,8746,982,884,9838,338,232,82311,500,890,95415,008,876,11815,535,291,26317,545,397,26719,462,501,27719,462,501,27719,845,534,61420,470,766,08421,246,784,960
Net income
281m
-18.74%
63,624,64090,513,947108,283,128109,327,457113,479,752115,523,102130,578,922180,324,653255,888,926266,627,877305,870,615345,155,498345,155,504363,530,318345,644,724280,883,792
CFO
688m
+19.21%
28,006,22200177,889,035219,30800126,770,170077,222,6450232,186,4451,309,117,195577,483,453688,400,138
Dividend
Jul 10, 20250.35 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Luyan Pharma Co.,Ltd. is a Chinese enterprise dedicated to the complete lifecycle of human health products, from their initial research and development through manufacturing and ultimate market distribution. Additionally, the company manages its own pharmaceutical distribution channels and a network of direct retail pharmacies. Originally established as Luyan (Fujian) Pharma Co. Ltd., the firm rebranded and adopted its current name, Luyan Pharma Co.,Ltd., in June 2016. This company was founded in 1992 and maintains its principal offices in Xiamen, China.
IPO date
Feb 18, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT